Home > Category > Signaling Pathways > Angiogenesis > VEGFR > Lenvatinib Mesylate | E7080 mesylate | ER-203492-00 | Lenvima

Lenvatinib Mesylate | E7080 mesylate | ER-203492-00 | Lenvima

ChemLeader Purity: 99.72%

Catalog No：CL2329 CAS No.：857890-39-2 MDLNo： Formula：C21H19ClN4O4.CH4O3S MW：522.96

Collect Share

Size	Availability	Price(USD)	VIP Price (USD)	Quantity
There is no price information at the moment, you can send an inquiry,and we will reply to you as soon as possible.

Chemical safety data sheet(MSDS)

Download MSDS

Certificate Of Authenticity(CPA)

Download COA

Inquiry Add To Cart

Product Overview
Related documents
Product details
Related literature

Product Overview

Product Name	Lenvatinib Mesylate \| E7080 mesylate \| ER-203492-00 \| Lenvima
CAS	857890-39-2
Formula	C21H19ClN4O4.CH4O3S
MW	522.96
Appearance	Off-white powder
Storage condition	Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years).

Product details

Lenvatinib Mesylate is a synthetic, orally available tyrosine kinase inhibitor that inhibits vascular endothelial growth factor receptor (VEGFR1-3), fibroblast growth factor receptor (FGFR1-4), platelet-derived growth factor receptor α (PDGFRα), stem cell factor receptor (Kit (c-Kit)), and rearranged during transfection (RET (c-RET)). Lenvatinib Mesylate has potential antineoplastic activity.

Related literature

Sorry, there is no relevant literature

History

Lenvatinib Mesylate | E7080 mesylate | ER-203492-00 | Lenvima

857890-39-2 Purity: 99.72%